IL13RA2 and glioma: Bernardi et al. used PEGylated interleukin-13 receptor-alpha 2 antibody-tagged gold-silica nanoshells (PEG-IL13Rα2-AuNS) as PTT strategy against U373 and U87 MG glioma cells (28).